Most Squamous Cell Carcinomas are Found in the Head and Neck Region.

Published Date: 27 Apr 2023

According to recent data on Medicare beneficiaries in the US, squamous cell carcinomas are more frequently found in the head and neck region of the body than in other places.

Read Full News

Latest News

Fatty Pancreas Linked to Risk for T2D and CKD

Moderate-to-severe fatty pancreas is independently linked to a higher risk for incident type 2 diabetes and chronic kidney disease.

Pharmacist-Led Drug Management for HFrEF Cost Effective

New data suggest an approach that could improve the use of guideline-directed medical therapy among patients with heart failure with reduced ejection fraction.

New Wearable Ultrasound Pacemaker Works Outside the Body

A noninvasive ultrasound device restored heart rhythm in animal models and engineered human heart cells, paving the way for pacemakers without implantation.

Dental Preset for CTA Best Minimises Knee Implant Artefacts

A dental reconstruction setting provides the strongest reduction in metal artefacts during photon-counting CT angiography of the lower leg among patients with total knee replacements.

Warnings Strengthened on Alopecia Areata Medicine Litfulo

The drug should be used in certain patients only if suitable treatment alternatives are not available.

Do Weight-Loss Drugs Improve Heart Health, Quality of Life?

A network meta-analysis of 19 weight-loss drugs concludes that most obesity drugs don’t improve quality of life or cardiovascular health.

Todays Updates

PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC

Study adds to evidence that the widely used medications may interfere with immunotherapy efficacy via effects on the gut microbiome.

FDA Approves Subcutaneous Isatuximab for MM Indications

The drug can now be administered with the hands-free automated CirCLIQ on-body injector.

Todays Updates

PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC

Study adds to evidence that the widely used medications may interfere with immunotherapy efficacy via effects on the gut microbiome.

FDA Approves Subcutaneous Isatuximab for MM Indications

The drug can now be administered with the hands-free automated CirCLIQ on-body injector.

Latest News

Moderate-to-severe fatty pancreas is independently linked to a higher risk for incident type 2 diabetes and chronic kidney disease.

New data suggest an approach that could improve the use of guideline-directed medical therapy among patients with heart failure with reduced ejection fraction.

A noninvasive ultrasound device restored heart rhythm in animal models and engineered human heart cells, paving the way for pacemakers without implantation.

A dental reconstruction setting provides the strongest reduction in metal artefacts during photon-counting CT angiography of the lower leg among patients with total knee replacements.

The drug should be used in certain patients only if suitable treatment alternatives are not available.

A network meta-analysis of 19 weight-loss drugs concludes that most obesity drugs don’t improve quality of life or cardiovascular health.

News All Time

Case Report: Cannabis and Compulsive Showering

An unexpected effect of chronic marijuana use

Chronically Short Sleep May Lead to Weight Gain in Adults With Heart Risks

Pooled analysis of two trials shows impact when losing just 1.5 hours a night

When Endurance Training Can Be Deadly for Older Athletes

This case shows the danger of one asymptomatic condition in particular

Cardiologist Runs for Mayor; PCSK9 Inhibitor Price Drops; Pregnancy OK After AVR?

Recent developments of interest in cardiovascular medicine

ASPECTS Fails to Reflect Ceiling for Endovascular Stroke Therapy Benefit

Quantitative volumetry better avoids futile reperfusion, per a nationwide study

Chronic Kidney Disease Increasingly Driven By Diabetes

Despite treatment advances, kidney disease burden remained unchanged over the past decade

Giant Cell Arteritis: Are Steroids Overused?

Chronic dosing at levels high enough to cause adverse effects remains common, French data show

A Better Idea of When Mild HCM Is Likely to Go Downhill Fast

— Natural history study probes predictors of worsening in mild disease

Lower Right Heart Reserve Linked to Worse Shunt Outcomes

In patients with heart failure, a lower TAPSE/PASP ratio is linked to higher rates of cardiovascular death or heart failure hospitalisation after interatrial shunting.

Dapagliflozin Cuts Heart Risk in T2D With Advanced Fibrosis

Dapagliflozin can reduce the risk for major adverse cardiovascular events in patients with T2D at a high risk for advanced liver fibrosis, according to a retrospective study.

CMS Proposes TAVR Coverage Framework

Treating patients with symptomatic aortic stenosis does not require collecting further evidence.

Stopping Aspirin Early May Cut Bleeding Risk After Stents

Stopping aspirin early in dual antiplatelet therapy is tied to a lower risk for bleeding with no increase in ischemic risks after coronary stenting, a new meta-analysis finds.

Obesity Drives 1 in 7 Polypharmacy Cases in Older US Adults

A US cohort study finds that BMI-defined obesity accounts for approximately 15% of polypharmacy cases among older adults, representing an estimated 3.3 million cases.

Why Men Account for Most Drowning Deaths

Drowning deaths are much more common among men, with overconfidence, alcohol, and open-water exposure emerging as key risk factors.

Recognizing Recurrent MI Risk: Identifying High-Risk Patients and Clinical Consequences

Recognizing Recurrent MI Risk: Identifying High-Risk Patients and Clinical Consequences

From Evidence to Practice: Individualizing P2Y12 Strategies in Recurrent MI Management

From Evidence to Practice: Individualizing P2Y12 Strategies in Recurrent MI Management

Recommended News For You

Both DNA damage repair deficiency and non-Hodgkin lymphoma are the focus of LP-284.

Antitumor cell activity in glioblastoma is controlled by blocking the triggering receptor expressed on myeloid cells 2.

Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey

Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes

Top FDA Official Exits; SCOTUS Takes Up Obamacare Case; Texas Doc Suspended

Browse the NBE-Released Curriculum at FNB Head and Neck Oncology.

EMA OKs Two Treatments for Small Cell Lung Cancer

Recommended Articles For You

How is Digital Innovation Revolutionizing Gynecologic Oncology Treatment and Patient Engagement? 

Everything You Need to Know About Normal Potassium Levels  

Immuno-Oncology in Daily Practice: Transforming Cancer Care One Patient at a Time 

Surprising Symptoms of Prostate Cancer: What You Need to Know 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Beyond What Is Visible in Myelofibrosis?

2.

The risk of cancer is decreased by following international health recommendations.

3.

Chemotherapy can be a challenging treatment?here's how to deal with some of the side-effects

4.

Cancer Patients' Depression May Be Helped by Psilocybin.

5.

Basal stem-like cells identified as origin of small cell lung cancer in lab models

1.

Precision Risk Interception in Oncology: A Comprehensive Review

2.

Critical Care Challenges in Oncologic Emergencies

3.

Understanding Pomalidomide: A promising drug for multiple myeloma treatment

4.

Ear Emergency: Understanding the Causes and Treatment for Auricular Hematoma

5.

Essential Concepts in Oncology for Better Care

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

2.

Efficient Management of First line ALK-rearranged NSCLC - Part VI

3.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot